20.3 Resource Management and Care Coordination

The current Test Content Outline lists resource management under Domain IV Implementation, with official parentheticals of accessibility, coordination, and cost-effectiveness. That is why a follow-up chapter still has to teach it. ANCC will not give you a health-economics seminar. It will give you an uninsured 54-year-old who needs an ACE inhibitor and a statin, a rural 80-year-old who cannot reach the clinic, or a glucagon-like peptide-1 receptor agonist stuck in prior authorization, and ask what the FNP does so the plan exists in the real world.

Resource management is not “be nice about money.” It is how Implementation either happens or dies in the parking lot. A perfect guideline that the patient cannot fill, cannot reach, or cannot understand is an Implementation failure that Evaluation will later score as nonadherence.

Accessibility is a clinical vital sign

Ask whether the patient can get in the door — or onto the video visit — and leave with the intervention. Language access (a qualified interpreter, not a 12-year-old child), disability access, after-hours options, broadband, childcare, and miles of dirt road are part of the plan. A Friday 4:50 p.m. “follow up Monday at 8:00 a.m. downtown” for a night-shift worker without a car is not coordination. It is a designed no-show.

Reducing no-shows is therefore an FNP skill, not a front-desk hobby. Evidence-informed tactics are reminder texts or calls, confirmation the day before, same-day or evening access, Medicaid or volunteer transportation, a booked interpreter, and telehealth when the exam allows. Chronic no-show is social-determinant and access work until you have ruled those out. Labeling the patient “noncompliant” and discharging them from clinic is how you manufacture an emergency-department frequent flyer.

Coordination means a named next owner

Coordination is closed-loop. You do not “refer to cardiology” and hope. You send a question, attach the data, state urgency, and confirm the appointment or the reason it failed. The same loop applies to social work (benefits, housing, intimate-partner violence, placement), community health workers (trust, navigation, food, rides), home health (skilled nursing, new insulin teaching, wounds — the patient generally needs to be homebound for Medicare skilled home health), occupational and physical therapy (falls, post-stroke, post-fracture, activity of daily living), WIC (pregnant, postpartum, and young-child nutrition), and insurance navigators or marketplace assisters at open enrollment.

Interprofessional primary care is the FNP plus the people who make the plan survivable: clinical pharmacist (medication therapy management and prior-auth letters), behavioral-health clinician, diabetes care and education specialist, registered dietitian, and the hospitalist or specialist who actually sent a note back. You do not hoard every problem to prove the FNP role. You also do not dump the whole problem list on social work and leave.

High-risk hospital follow-up from Section 20.1 is coordination: outreach within about 2 business days, visit within 7 days when risk is high, bottle-by-bottle reconciliation, and a phone number that a human answers.

Cost-effectiveness is not “cheapest always”

Cost-effectiveness is outcome per dollar, filtered through adherence. The cheapest tablet that causes a hypoglycemic motor-vehicle crash, a heart-failure admission, or an abandoned bottle is expensive. The brand-name product with no outcome advantage over a guideline generic is also expensive. Your job is the high-value choice the patient will take.

Low-cost or “$4” lists are excellent when the generic is the right drug: lisinopril, amlodipine, chlorthalidone or hydrochlorothiazide when a thiazide is appropriate, metformin, atorvastatin, sertraline. They are a trap when you pick hydrochlorothiazide instead of an indicated ACE inhibitor in diabetic albuminuria “because it is on the $4 list,” or a sulfonylurea instead of an indicated SGLT2 inhibitor in heart failure because the brand needs a prior authorization. Cost stewardship does not authorize you to ignore the organ-protection chapter.

Prior authorization is a coordination task. Document the indication, the guideline, the ICD-10 code that matches the chart, and the preferred alternatives already tried when those alternatives are clinically equivalent. Do not delay insulin, a severely depressed patient with suicide risk, or a child who cannot breathe while you wait for a letter with no bridge plan. Offer a temporary covered alternative, samples only as a true bridge (not a business model), a 340B or patient-assistance path, or a same-week appeal. Teach the patient what “denied” means so they do not assume you abandoned them.

340B is a federal drug-pricing program for eligible safety-net hospitals and clinics. Conceptually, participating covered entities can purchase outpatient drugs at a ceiling price and pass savings to uninsured or underinsured patients through their pharmacy. It is a resource, not a license to prescribe anything and not a reason to ignore interactions. If the stem places the patient in a federally qualified health center or a 340B hospital clinic, using that pharmacy can be the Implementation answer.

Patient-assistance programs, GoodRx-style cash prices, and splitting a higher-dose tablet only when the tablet is scored and the pharmacokinetics allow are the same family of tools. Do not invent a coupon as a diagnosis.

Rural access and the limits of telehealth

Telehealth is a resource. Blood-pressure logs, heart-failure weight checks, depression follow-up after the safety plan is in place, contraception counseling, and many titration visits can happen on video or telephone when state law and payer rules allow. Rural patients should not lose 4 hours of wages for a 6-minute “your potassium is 4.2” visit.

Telehealth cannot replace every exam. You need hands, a table, or a procedure room for a new murmur, an acute abdomen, a diabetic foot you have not looked at, a pelvic examination, a poorly visualized or changing pigmented lesion, most office procedures, many neurologic deficits, and hearing or vision screens that need equipment. Some controlled-substance starts still require an in-person evaluation under federal rules (the Ryan Haight framework and its current exceptions). Do not assume every stimulant, opioid, or buprenorphine start can begin on a first-time video visit without checking the rule that applies. If the stem gives you a pixelated rash and asks for cryotherapy today, the resource answer is an in-person slot, not a stronger zoom lens.

Broadband, privacy (a teenager who cannot talk about sexual risk in the kitchen), and digital literacy are access issues. Offering only video to a household with no data plan is the opposite of accessibility.

How this looks on a scored item

A 54-year-old without insurance needs secondary-prevention atorvastatin and lisinopril after a stroke. Implementation is the $4 generics plus a navigator or 340B pharmacy, not a 90-day brand sample pack with no refill path. A 41-year-old with obesity, A1C 8.1%, and established atherosclerotic disease needs a GLP-1 receptor agonist that is delayed in prior authorization: file a complete medical-necessity letter, start or optimize metformin, add an SGLT2 inhibitor if the heart or kidney indication is there, and do not leave the patient on a “we will wait” plan with no date. An 80-year-old with heart failure 40 miles from clinic can do a telehealth weight and symptom check this week, but new unilateral swelling and a possible deep-vein thrombosis need an in-person exam and ultrasound, not another video.

Cost-effectiveness, accessibility, and coordination are the same three words as the TCO. If your plan cannot be filled, reached, or afforded, you have not implemented it — and you will not have anything honest to evaluate at the 1-month visit.